XML 49 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment and Geographic Data
 12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Segment and Geographic Data SEGMENT AND GEOGRAPHIC DATA
We segregate our operations into two reportable business segments: (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine which aligns to our internal reporting structure and how the Company manages its businesses.
The Corporate and Other category shown in the table below includes corporate and administration, corporate initiatives and share-based compensation, which includes compensation related to employee stock options, restricted stock units and performance stock unit grants and director stock options and restricted stock unit grants.
Segment Results202320222021
MedSurg and Neurotechnology$11,836 $10,611 $9,538 
Orthopaedics and Spine8,662 7,838 7,570 
Net sales$20,498 $18,449 $17,108 
MedSurg and Neurotechnology$564 $540 $518 
Orthopaedics and Spine637 614 629 
Segment depreciation and amortization $1,201 $1,154 $1,147 
Corporate and Other140 124 125 
Total depreciation and amortization$1,341 $1,278 $1,272 
MedSurg and Neurotechnology$3,336 $2,737 $2,807 
Orthopaedics and Spine2,399 2,296 2,180 
Segment operating income$5,735 $5,033 $4,987 
Items not allocated to segments:
Corporate and Other$(780)$(649)$(605)
Acquisition and integration-related charges(20)(150)(585)
Amortization of intangible assets(635)(627)(619)
Structural optimization and other special charges(206)(349)(386)
   Goodwill impairment— (216)— 
Medical device regulations(96)(140)(107)
Recall-related matters(18)15 (103)
Regulatory and legal matters(92)(76)2 
Consolidated operating income$3,888 $2,841 $2,584 
Segment Assets and Capital Spending
Assets:20232022
MedSurg and Neurotechnology$20,514 $18,487 
Orthopaedics and Spine18,313 17,466 
Total segment assets$38,827 $35,953 
Corporate and Other1,085 931 
Total assets$39,912 $36,884 
Purchases of property, plant and equipment:202320222021
MedSurg and Neurotechnology$179 $173 $197 
Orthopaedics and Spine183 175 165 
Total segment purchases of property, plant and equipment$362 $348 $362 
Corporate and Other213 240 163 
Total purchases of property, plant and equipment$575 $588 $525 
We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, structural optimization and other special charges, goodwill impairment, reserves for certain product recall matters and reserves for certain legal and regulatory matters. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally property, plant and equipment and noncurrent assets. Certain assets in 2022 have been reallocated to the segments to conform with current year presentation.
The countries in which we have local revenue generating operations have been combined into the following geographic areas: the United States; Europe, Middle East, Africa; Asia Pacific; and other foreign countries, which include Canada and countries in the Latin American region. Net sales are reported based on the geographic area of the Stryker location where the sales to the customer originated.
Geographic Information
Net SalesNet Property, Plant and Equipment
20232022202120232022
United States$15,257 $13,638 $12,321 $1,874 $1,791 
Europe, Middle East, Africa2,618 2,348 2,299 1,151 995 
Asia Pacific1,946 1,885 1,973 77 76 
Other countries677 578 515 113 108 
Total$20,498 $18,449 $17,108 $3,215 $2,970